NCT07423715Not yet recruiting
Key Technical Research on the Treatment of Post-stroke Cognitive Impairment With Brain Electric Field Therapy Based on Acupoint Regulation
Source: ClinicalTrials.gov · Last updated 20 Feb 2026
Brief summary (registry, in English)
This clinical study investigates whether electroacupuncture can improve thinking and memory in people with cognitive problems after a stroke (Post-Stroke Cognitive Impairment, or PSCI). Participants will be randomly assigned to one of two groups: one group will receive real electroacupuncture, while the other will receive a sham treatment . Both groups will also receive standard medical care.The main goal is to see if the real electroacupuncture leads to greater improvement in cognitive function tests over 6 months compared to the sham treatment. The study will also use brain scans (MRI) and other assessments to understand how the treatment might work.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 110 (estimated)
- First submitted
- 9 Feb 2026
- Start date
- 10 Feb 2026
- Primary completion date
- 31 Dec 2027
- Lead sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Diseases
- Stroke
- NCT number
- NCT07423715
What you commit to
- Study type: Interventional
- Planned participants: 110
- From 10 Feb 2026 to the primary completion date, 31 Dec 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe chronic systemic diseases (e.g., cardiac, hepatic, renal, hematologic) or unstable cardiovascular/cerebrovascular disease.
- Local skin conditions (e.g., herpes, ulceration, keloid) contraindicating acupuncture.
- Pre-existing cognitive impairment or other major uncontrolled neurological/psychiatric disorders.
Other
- Contraindications for repeated MRI (e.g., claustrophobia, post-aneurysm embolization).
- Deemed unsuitable for the study by investigators.
- Participation in another clinical trial within the past 3 months.
Who the study is looking for
- Meets diagnostic criteria for Vascular Cognitive Impairment (VCI) per the 2024 Chinese VCI guidelines.
- Meets TCM diagnostic criteria per the 2024 Vascular Mild Cognitive Impairment guidelines.
- Cognitive scores: MMSE 12-24 and MoCA \<24; NIHSS ≤8; AD-8 \<2.
- Age 35-80 years.
- Basic communication ability (Mandarin) and has a stable caregiver.
- Provides written informed consent.
Age in the registry: 35 years to 80 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.